AventaMed DAC news
AventaMed will exhibit at the 2018 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, October 7 – 10th in Atlanta, Georgia. Come say hello to us at booth 3326 and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
In its 122nd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynamic evening events drawing more than 5,500 o
AventaMed will exhibit at the 2019 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, September 15th – 18th in New Orleans, LA. Come say hello to us at booth 432 in the Emerging Technologies Pavillion and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
In its 123rd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynami
CORK MEDTECH STARTUP AventaMed has joined a consortium of big-name healthcare companies for collaborations ahead of a planned US launch.
AventaMed has developed a device for inserting grommets into the eardrum, which prevents the build up of fluid.
The consortium – called the National Evaluation System for Health Technology Coordinating Center (NESTcc) – connects regulators and the industry to share and evaluate real-world evidence in the regulatory process for med
AventaMed, a Cork-based medical device start-up which is set to revolutionise paediatric ear, nose and throat surgery has beaten 26 global organizations in a major medical device bid.
The pioneering company will be one of 12 Real-World Evidence Test-Cases selected by The National Evaluation System for Health Technology Coordinating Center (NESTcc) to evaluate the use of real-world evidence (RWE) in medical device regulatory processes.
AventaMed is the first and only Irish comp
The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), announces twelve new Test-Cases which leverage Real-World Evidence (RWE) and address key priorities for medical device stakeholders. These Test-Cases are intended to accelerate NESTcc’s progress and provide proof of concept for NESTcc’s ability to generate high-quality RWE for a range of medical devices through the
AventaMed will exhibit at the 20th International Symposium on Recent Advances in Otitis Media at the Loews Hollywood in Los Angeles, CA on June 9 – 13, 2019.
Come say hello to us at booth 5 and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
The International Society for Otitis Media is a non-profit organization that provides an international forum to adv
AventaMed are delighted to partner with PROSA for the 1st European Conference on Pediatric Procedural Sedation and Analgesia in Maastricht, The Netherlands, November 29th & 30th 2018.
Come say hello to us at booth 7 and learn more about the Solo TTD. For more information or to schedule a meeting, contact ciara.omahony@aventamed.com
PSA represents a relatively new field in modern medicine, involving a heterogeneous group of medical professions. During this conference you wi
September 14-16th 2018, Hilton Financial District Hotel, San Francisco
AventaMed will exhibit at the “Pediatric Sedation Outside the Operating Room” Conference, come say hello at our booth and learn about the Solo TTD.
If you would like to arrange to meet with a member of our team at this event, please contact info@aventamed.com
Cork medtech firm seeks FDA clearance for Solo Tympanostomy Tube Device
Cork Institute of Technology spin-out AventaMed has completed a €1.8 million funding round led by Halo Business Angel Network (HBAN).
The investment will fund AventaMed through FDA (Food and Drug Administration) clearance and commercialisation of the Solo Tympanostomy Tube Device (Solo TTD) which enables the quick and simple insertion of ear grommets.
AventaMed was set up by Olive O’Dris
HBAN (Halo Business Angel Network), the all-island organisation responsible for the promotion of business angel investment and a joint initiative of Enterprise Ireland and InterTradeIreland, today announces a €1.8 million investment in Cork-based medtech company, AventaMed. The investment – which includes €1.6 million angel funding, the largest single HBAN angel investment to date – will fund AventaMed through FDA (Food and Drug Administration) clearance and commercialis